Seres Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Seres Therapeutics Inc
CIK #0001609809
EDGAR Form CIK 2011 - 2026
10-K [0001609809]
10-Q [0001609809]
3 [0001609809]
4 [0001609809]
8-K [0001609809]
D [0001609809]
SC 13D [0001609809]
SC 13G [0001609809]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Seres Therapeutics Inc [2024-01-29]
BlackRock Inc Seres Therapeutics Inc [2023-02-03]
Federated Hermes Inc Seres Therapeutics Inc [2022-02-14]
Janus Henderson Group PLC Seres Therapeutics Inc [2022-02-11]
Vanguard Group Inc Seres Therapeutics Inc [2022-02-10]
State Street Corp Seres Therapeutics Inc [2021-10-12]
RA Capital Management LP Seres Therapeutics Inc [2021-05-05]
BlackRock Inc Seres Therapeutics Inc [2020-02-07]
Sumitomo Mitsui Trust Holdings Inc Seres Therapeutics Inc [2019-09-09]
Nikko Asset Management Americas Inc Seres Therapeutics Inc [2019-09-06]
View All
Form 3/4/5 Subject 2011 - 2026
Seres Therapeutics Inc
Ausiello Dennis A
Berenson Stephen
Rosiello Robert L
Henn Matthew R
Shaff Eric D
Brady Kelly
DesRosier Thomas
Thorell Marella
Kender Richard N
Young Teresa L
Fraser Claire
Dere Willard H
Biondi Paul
Graves Kurt
von Moltke Lisa
Woerle Hans-Juergen
Societe des Produits Nestle SA
Nestle Sa
Ege David S
Arkowitz David
Cloghessy Paula
Behar Gregory
Flagship Pioneering Fund VII General Partner LLC
Flagship Pioneering Fund VII LP
Nutritional Health LTP Fund LP
Flagship Pioneering LLC
Afeyan Noubar
Nutritional Health LTP Fund General Partner LLC
Zausner Meryl
Chapman Marcus
Flagship Ventures Fund IV LP
Flagship Ventures Fund IV General Partner LLC
Flagship Pioneering Fund VI General Partner LLC
Flagship Pioneering Fund VI LP
Flagship Ventures Fund IV-RX LP
Aunins John G
Kim Lorence H
Pomerantz Roger
Horgan Kevin
Cook David N
Trucksis Michele
Hashad Wael
HUTT Peter Barton
Flagship Ventures 2007 General Partner LLC
Flagship VentureLabs IV LLC
Flagship Ventures Fund 2007 LP
Kania Edwin
Nestle Health Science US Holdings Inc
Nimco US Inc
Cautreels Werner
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Seres Therapeutics Inc MCRB
Stock Option (right to buy) · derivative
2026-03-04 Grant 150,000 $0.00
Seres Therapeutics Inc MCRB
Stock Option (right to buy) · derivative
2026-03-04 Grant 22,500 $0.00
Seres Therapeutics Inc MCRB
Stock Option (right to buy) · derivative
2026-03-04 Grant 56,250 $0.00
Seres Therapeutics Inc MCRB
Stock Option (right to buy) · derivative
2026-03-04 Grant 75,000 $0.00
Seres Therapeutics Inc MCRB
Stock Option (right to buy) · derivative
2026-03-04 Grant 22,500 $0.00
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Option exercise 723
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 141 $0.00
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 391 $0.00
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 98 $0.00
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Option exercise 231
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Sell 78 $8.47 661
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 111 $0.00
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Sell 259 $8.47 2,194
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Option exercise 244
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 133 $0.00
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 98 $0.00
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Sell 75 $8.47 635
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 333 $0.00
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Sell 89 $8.47 754
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 133 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com